BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8740577)

  • 1. 4-Pentafluoroethylumbelliferyl-beta-D-glucoside as a new fluorogenic substrate for acid beta-D-glucosidase.
    Tsvetkova IV; Karpova EA; Dudukina TV; Voznyi YV
    Clin Chim Acta; 1996 Apr; 248(2):125-33. PubMed ID: 8740577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Glucosidase assays in the diagnosis of Gaucher's disease.
    Daniels LB; Glew RH
    Clin Chem; 1982 Apr; 28(4 Pt 1):569-77. PubMed ID: 6804115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enzymatic hydrolysis of 6-acylamino-4-methylumbelliferyl-beta-D-glucosides: identification of a novel human acid beta-glucosidase.
    Mikhaylova M; Wiederschain G; Mikhaylov V; Aerts JM
    Biochim Biophys Acta; 1996 Oct; 1317(1):71-9. PubMed ID: 8876629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay of the beta-glucosidase activity with natural labelled and artificial substrates in leukocytes from homozygotes and heterozygotes with the Norrbottnian type (Type 3) of Gaucher disease.
    Svennerholm L; Håkansson G; Dreborg S
    Clin Chim Acta; 1980 Sep; 106(2):183-93. PubMed ID: 6773705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitfalls in the use of artificial substrates for the diagnosis of Gaucher's disease.
    Ben-Yoseph Y; Nadler HL
    J Clin Pathol; 1978 Nov; 31(11):1091-3. PubMed ID: 105017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 4-heptylumbelliferyl-beta-D-glucoside to identify Gaucher's disease heterozygotes.
    Butcher BA; Gopalan V; Lee RE; Richards TC; Waggoner AS; Glew RH
    Clin Chim Acta; 1989 Oct; 184(3):235-42. PubMed ID: 2515009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygote detection of type I Gaucher disease using blood platelets.
    Nakagawa S; Kumin S; Sachs G; Nitowsky HM
    Clin Chim Acta; 1982 Jan; 118(1):99-107. PubMed ID: 6797762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and stability assay of 4-methylumbelliferyl (1-->3)-beta-D-pentaglucoside.
    Huang G
    J Enzyme Inhib Med Chem; 2009 Apr; 24(2):453-6. PubMed ID: 18608765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of serum acid phosphatase in Gaucher's disease using 4-methylumbelliferyl phosphate.
    Chambers JP; Aquino L; Glew RH; Lee RE; McCafferty LR
    Clin Chim Acta; 1977 Oct; 80(1):67-77. PubMed ID: 20252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Glucosidase activities in the Norrbotten type of juvenile Gaucher's disease.
    Hultberg B
    Acta Neurol Scand; 1978 Aug; 58(2):89-94. PubMed ID: 30251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis of Gaucher's disease in liver using 4-methylumbelliferyl-beta-D-glucopyranoside.
    Broadhead DM; Butterworth J
    Clin Chim Acta; 1977 Feb; 75(1):155-61. PubMed ID: 14796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of a cytosolic broad specificity beta-glucosidase from human liver.
    Daniels LB; Coyle PJ; Chiao YB; Glew RH; Labow RS
    J Biol Chem; 1981 Dec; 256(24):13004-13. PubMed ID: 6796580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical study on beta-glucosidase in individuals with Gaucher's disease and normal subjects.
    Michelin K; Wajner A; Goulart Lda S; Fachel AA; Pereira ML; de Mello AS; Souza FT; Pires RF; Giugliani R; Coelho JC
    Clin Chim Acta; 2004 May; 343(1-2):145-53. PubMed ID: 15115687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaucher disease (type 1): physical and kinetic properties of liposomal and soluble 'acid' beta-glucosidase.
    Carroll M
    J Inherit Metab Dis; 1985; 8(1):33-7. PubMed ID: 3921758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease.
    Raghavan SS; Topol J; Kolodny EH
    Am J Hum Genet; 1980 Mar; 32(2):158-73. PubMed ID: 6770675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid beta-glucosidase and the diagnosis of Gaucher's disease in liver and spleen.
    Butterworth J; Broadhead DM
    Clin Chim Acta; 1978 Aug; 87(3):433-40. PubMed ID: 28186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis of beta-maltosides, derivatives of p-nitrophenol, 2-chloro-4-nitrophenol, and 4-methylumbelliferone, and their use as substrates for determining alpha-glucosidase activity].
    Voznyĭ IaV; Lukomskaia IS; Lanskaia IM; Podkidysheva EI
    Vopr Med Khim; 1996; 42(4):348-54. PubMed ID: 9254525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic substrate beta-glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher's disease.
    Wenger DA; Clark C; Sattler M; Wharton C
    Clin Genet; 1978 Feb; 13(2):145-53. PubMed ID: 23912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaucher disease: accurate identification of asymptomatic French-Canadian carrier using nonlabeled authentic sphingolipid substrate N-palmitoyl dihydroglucocerebroside.
    Choy FY; Bouillon L; Laurin CA
    Am J Med Genet; 1987 Aug; 27(4):895-905. PubMed ID: 3425599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver.
    Owada M; Sakiyama T; Kitagawa T
    Pediatr Res; 1977 May; 11(5):641-6. PubMed ID: 870871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.